aluates Reports

$ 0.0

Automative

Global Drugs of Bioengineered Protein Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-29F9554

Global Drugs of Bioengineered Protein Market Insights and Forecast to 2028

BUY CHAPTERS

Global Drugs of Bioengineered Protein Market Research Report 2025

Code: QYRE-Auto-29F9554

Report

July 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Johnson & Johnson

Merck

Novartis

Sanofi

Eli Lilly

Roche

Dr. Reddy’s Laboratories

Abbott Laboratories

Amgen Inc

Bayer

Biocon Ltd.

Fresenius Kabi

Panacea Biotec

Drugs of Bioengineered Protein Market Size

The global market for Drugs of Bioengineered Protein was valued at US$ 3716 million in the year 2024 and is projected to reach a revised size of US$ 5556 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Drugs of Bioengineered Protein Market

Bioengineered proteins are synthesized using genetic engineering. They are also called as recombinant protein. Bioengineered protein drugs are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drugs of Bioengineered Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of Bioengineered Protein.

The Drugs of Bioengineered Protein market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs of Bioengineered Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs of Bioengineered Protein companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs of Bioengineered Protein Market Report

Report Metric	Details
Report Name	Drugs of Bioengineered Protein Market
Accounted market size in year	US$ 3716 million
Forecasted market size in 2031	US$ 5556 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Therapeutic Proteins Vaccines
Segment by Application	Endocrinology Immunology Hematology Infectiology Neurology Oncology Genetic Disorder
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche, Dr. Reddy's Laboratories, Abbott Laboratories, Amgen, Bayer AG, Biocon, Fresenius kabi, Panacea Biotec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs of Bioengineered Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs of Bioengineered Protein Market growing?

Ans: The Drugs of Bioengineered Protein Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Drugs of Bioengineered Protein Market size in 2031?

Ans: The Drugs of Bioengineered Protein Market size in 2031 will be US$ 5556 million.

Who are the main players in the Drugs of Bioengineered Protein Market report?

Ans: The main players in the Drugs of Bioengineered Protein Market are GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche, Dr. Reddy's Laboratories, Abbott Laboratories, Amgen, Bayer AG, Biocon, Fresenius kabi, Panacea Biotec

What are the Application segmentation covered in the Drugs of Bioengineered Protein Market report?

Ans: The Applications covered in the Drugs of Bioengineered Protein Market report are Endocrinology, Immunology, Hematology, Infectiology, Neurology, Oncology, Genetic Disorder

What are the Type segmentation covered in the Drugs of Bioengineered Protein Market report?

Ans: The Types covered in the Drugs of Bioengineered Protein Market report are Monoclonal Antibodies, Therapeutic Proteins, Vaccines

Recommended Reports

Biopharma Market Trends

Drug Development & Therapy

Pharmaceutical Innovation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs of Bioengineered Protein Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Therapeutic Proteins

1.2.4 Vaccines

1.3 Market by Application

1.3.1 Global Drugs of Bioengineered Protein Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Endocrinology

1.3.3 Immunology

1.3.4 Hematology

1.3.5 Infectiology

1.3.6 Neurology

1.3.7 Oncology

1.3.8 Genetic Disorder

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs of Bioengineered Protein Market Perspective (2020-2031)

2.2 Global Drugs of Bioengineered Protein Growth Trends by Region

2.2.1 Global Drugs of Bioengineered Protein Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drugs of Bioengineered Protein Historic Market Size by Region (2020-2025)

2.2.3 Drugs of Bioengineered Protein Forecasted Market Size by Region (2026-2031)

2.3 Drugs of Bioengineered Protein Market Dynamics

2.3.1 Drugs of Bioengineered Protein Industry Trends

2.3.2 Drugs of Bioengineered Protein Market Drivers

2.3.3 Drugs of Bioengineered Protein Market Challenges

2.3.4 Drugs of Bioengineered Protein Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs of Bioengineered Protein Players by Revenue

3.1.1 Global Top Drugs of Bioengineered Protein Players by Revenue (2020-2025)

3.1.2 Global Drugs of Bioengineered Protein Revenue Market Share by Players (2020-2025)

3.2 Global Drugs of Bioengineered Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drugs of Bioengineered Protein Revenue

3.4 Global Drugs of Bioengineered Protein Market Concentration Ratio

3.4.1 Global Drugs of Bioengineered Protein Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs of Bioengineered Protein Revenue in 2024

3.5 Global Key Players of Drugs of Bioengineered Protein Head office and Area Served

3.6 Global Key Players of Drugs of Bioengineered Protein, Product and Application

3.7 Global Key Players of Drugs of Bioengineered Protein, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs of Bioengineered Protein Breakdown Data by Type

4.1 Global Drugs of Bioengineered Protein Historic Market Size by Type (2020-2025)

4.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2026-2031)

5 Drugs of Bioengineered Protein Breakdown Data by Application

5.1 Global Drugs of Bioengineered Protein Historic Market Size by Application (2020-2025)

5.2 Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drugs of Bioengineered Protein Market Size (2020-2031)

6.2 North America Drugs of Bioengineered Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drugs of Bioengineered Protein Market Size by Country (2020-2025)

6.4 North America Drugs of Bioengineered Protein Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs of Bioengineered Protein Market Size (2020-2031)

7.2 Europe Drugs of Bioengineered Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drugs of Bioengineered Protein Market Size by Country (2020-2025)

7.4 Europe Drugs of Bioengineered Protein Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs of Bioengineered Protein Market Size (2020-2031)

8.2 Asia-Pacific Drugs of Bioengineered Protein Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2020-2025)

8.4 Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs of Bioengineered Protein Market Size (2020-2031)

9.2 Latin America Drugs of Bioengineered Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drugs of Bioengineered Protein Market Size by Country (2020-2025)

9.4 Latin America Drugs of Bioengineered Protein Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs of Bioengineered Protein Market Size (2020-2031)

10.2 Middle East & Africa Drugs of Bioengineered Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2020-2025)

10.4 Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Introduction

11.1.4 GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Drugs of Bioengineered Protein Introduction

11.2.4 Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Drugs of Bioengineered Protein Introduction

11.3.4 Merck Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Drugs of Bioengineered Protein Introduction

11.4.4 Novartis Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Drugs of Bioengineered Protein Introduction

11.5.4 Sanofi Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Drugs of Bioengineered Protein Introduction

11.6.4 Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Drugs of Bioengineered Protein Introduction

11.7.4 Roche Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.7.5 Roche Recent Development

11.8 Dr. Reddy's Laboratories

11.8.1 Dr. Reddy's Laboratories Company Details

11.8.2 Dr. Reddy's Laboratories Business Overview

11.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Introduction

11.8.4 Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.8.5 Dr. Reddy's Laboratories Recent Development

11.9 Abbott Laboratories

11.9.1 Abbott Laboratories Company Details

11.9.2 Abbott Laboratories Business Overview

11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Introduction

11.9.4 Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.9.5 Abbott Laboratories Recent Development

11.10 Amgen

11.10.1 Amgen Company Details

11.10.2 Amgen Business Overview

11.10.3 Amgen Drugs of Bioengineered Protein Introduction

11.10.4 Amgen Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.10.5 Amgen Recent Development

11.11 Bayer AG

11.11.1 Bayer AG Company Details

11.11.2 Bayer AG Business Overview

11.11.3 Bayer AG Drugs of Bioengineered Protein Introduction

11.11.4 Bayer AG Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.11.5 Bayer AG Recent Development

11.12 Biocon

11.12.1 Biocon Company Details

11.12.2 Biocon Business Overview

11.12.3 Biocon Drugs of Bioengineered Protein Introduction

11.12.4 Biocon Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.12.5 Biocon Recent Development

11.13 Fresenius kabi

11.13.1 Fresenius kabi Company Details

11.13.2 Fresenius kabi Business Overview

11.13.3 Fresenius kabi Drugs of Bioengineered Protein Introduction

11.13.4 Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.13.5 Fresenius kabi Recent Development

11.14 Panacea Biotec

11.14.1 Panacea Biotec Company Details

11.14.2 Panacea Biotec Business Overview

11.14.3 Panacea Biotec Drugs of Bioengineered Protein Introduction

11.14.4 Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2020-2025)

11.14.5 Panacea Biotec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Johnson & Johnson

Merck

Novartis

Sanofi

Eli Lilly

Roche

Dr. Reddy’s Laboratories

Abbott Laboratories

Amgen Inc

Bayer

Biocon Ltd.

Fresenius Kabi

Panacea Biotec

List of Tables

Table 1. Global Drugs of Bioengineered Protein Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Therapeutic Proteins

Table 4. Key Players of Vaccines

Table 5. Global Drugs of Bioengineered Protein Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drugs of Bioengineered Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drugs of Bioengineered Protein Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Drugs of Bioengineered Protein Market Share by Region (2020-2025)

Table 9. Global Drugs of Bioengineered Protein Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Drugs of Bioengineered Protein Market Share by Region (2026-2031)

Table 11. Drugs of Bioengineered Protein Market Trends

Table 12. Drugs of Bioengineered Protein Market Drivers

Table 13. Drugs of Bioengineered Protein Market Challenges

Table 14. Drugs of Bioengineered Protein Market Restraints

Table 15. Global Drugs of Bioengineered Protein Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Drugs of Bioengineered Protein Market Share by Players (2020-2025)

Table 17. Global Top Drugs of Bioengineered Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2024)

Table 18. Ranking of Global Top Drugs of Bioengineered Protein Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Drugs of Bioengineered Protein Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Drugs of Bioengineered Protein, Headquarters and Area Served

Table 21. Global Key Players of Drugs of Bioengineered Protein, Product and Application

Table 22. Global Key Players of Drugs of Bioengineered Protein, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drugs of Bioengineered Protein Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2020-2025)

Table 26. Global Drugs of Bioengineered Protein Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Drugs of Bioengineered Protein Revenue Market Share by Type (2026-2031)

Table 28. Global Drugs of Bioengineered Protein Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Drugs of Bioengineered Protein Revenue Market Share by Application (2020-2025)

Table 30. Global Drugs of Bioengineered Protein Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Drugs of Bioengineered Protein Revenue Market Share by Application (2026-2031)

Table 32. North America Drugs of Bioengineered Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Drugs of Bioengineered Protein Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Drugs of Bioengineered Protein Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Drugs of Bioengineered Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Drugs of Bioengineered Protein Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Drugs of Bioengineered Protein Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Drugs of Bioengineered Protein Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Drugs of Bioengineered Protein Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Drugs of Bioengineered Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Drugs of Bioengineered Protein Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Drugs of Bioengineered Protein Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Drugs of Bioengineered Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Drugs of Bioengineered Protein Market Size by Country (2026-2031) & (US$ Million)

Table 47. GlaxoSmithKline Company Details

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Drugs of Bioengineered Protein Product

Table 50. GlaxoSmithKline Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Johnson & Johnson Company Details

Table 53. Johnson & Johnson Business Overview

Table 54. Johnson & Johnson Drugs of Bioengineered Protein Product

Table 55. Johnson & Johnson Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 56. Johnson & Johnson Recent Development

Table 57. Merck Company Details

Table 58. Merck Business Overview

Table 59. Merck Drugs of Bioengineered Protein Product

Table 60. Merck Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 61. Merck Recent Development

Table 62. Novartis Company Details

Table 63. Novartis Business Overview

Table 64. Novartis Drugs of Bioengineered Protein Product

Table 65. Novartis Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. Sanofi Company Details

Table 68. Sanofi Business Overview

Table 69. Sanofi Drugs of Bioengineered Protein Product

Table 70. Sanofi Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 71. Sanofi Recent Development

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Drugs of Bioengineered Protein Product

Table 75. Eli Lilly Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 76. Eli Lilly Recent Development

Table 77. Roche Company Details

Table 78. Roche Business Overview

Table 79. Roche Drugs of Bioengineered Protein Product

Table 80. Roche Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 81. Roche Recent Development

Table 82. Dr. Reddy's Laboratories Company Details

Table 83. Dr. Reddy's Laboratories Business Overview

Table 84. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product

Table 85. Dr. Reddy's Laboratories Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 86. Dr. Reddy's Laboratories Recent Development

Table 87. Abbott Laboratories Company Details

Table 88. Abbott Laboratories Business Overview

Table 89. Abbott Laboratories Drugs of Bioengineered Protein Product

Table 90. Abbott Laboratories Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 91. Abbott Laboratories Recent Development

Table 92. Amgen Company Details

Table 93. Amgen Business Overview

Table 94. Amgen Drugs of Bioengineered Protein Product

Table 95. Amgen Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 96. Amgen Recent Development

Table 97. Bayer AG Company Details

Table 98. Bayer AG Business Overview

Table 99. Bayer AG Drugs of Bioengineered Protein Product

Table 100. Bayer AG Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 101. Bayer AG Recent Development

Table 102. Biocon Company Details

Table 103. Biocon Business Overview

Table 104. Biocon Drugs of Bioengineered Protein Product

Table 105. Biocon Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 106. Biocon Recent Development

Table 107. Fresenius kabi Company Details

Table 108. Fresenius kabi Business Overview

Table 109. Fresenius kabi Drugs of Bioengineered Protein Product

Table 110. Fresenius kabi Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 111. Fresenius kabi Recent Development

Table 112. Panacea Biotec Company Details

Table 113. Panacea Biotec Business Overview

Table 114. Panacea Biotec Drugs of Bioengineered Protein Product

Table 115. Panacea Biotec Revenue in Drugs of Bioengineered Protein Business (2020-2025) & (US$ Million)

Table 116. Panacea Biotec Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Drugs of Bioengineered Protein Picture

Figure 2. Global Drugs of Bioengineered Protein Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs of Bioengineered Protein Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Therapeutic Proteins Features

Figure 6. Vaccines Features

Figure 7. Global Drugs of Bioengineered Protein Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Drugs of Bioengineered Protein Market Share by Application: 2024 VS 2031

Figure 9. Endocrinology Case Studies

Figure 10. Immunology Case Studies

Figure 11. Hematology Case Studies

Figure 12. Infectiology Case Studies

Figure 13. Neurology Case Studies

Figure 14. Oncology Case Studies

Figure 15. Genetic Disorder Case Studies

Figure 16. Drugs of Bioengineered Protein Report Years Considered

Figure 17. Global Drugs of Bioengineered Protein Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Drugs of Bioengineered Protein Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Drugs of Bioengineered Protein Market Share by Region: 2024 VS 2031

Figure 20. Global Drugs of Bioengineered Protein Market Share by Players in 2024

Figure 21. Global Top Drugs of Bioengineered Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of Bioengineered Protein as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2024

Figure 23. North America Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Drugs of Bioengineered Protein Market Share by Country (2020-2031)

Figure 25. United States Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Drugs of Bioengineered Protein Market Share by Country (2020-2031)

Figure 29. Germany Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Drugs of Bioengineered Protein Market Share by Region (2020-2031)

Figure 37. China Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Drugs of Bioengineered Protein Market Share by Country (2020-2031)

Figure 45. Mexico Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Drugs of Bioengineered Protein Market Share by Country (2020-2031)

Figure 49. Turkey Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Drugs of Bioengineered Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 53. Johnson & Johnson Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 54. Merck Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 56. Sanofi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 57. Eli Lilly Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 58. Roche Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 59. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 60. Abbott Laboratories Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 61. Amgen Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 62. Bayer AG Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 63. Biocon Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 64. Fresenius kabi Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 65. Panacea Biotec Revenue Growth Rate in Drugs of Bioengineered Protein Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Genetically Modified Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Recombinant Protein Market Research Report 2024

Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biosynthesis Peptide Drugs Market Research Report 2024

Global 3D Bioengineered Skin Grafts Market Research Report 2025

Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fusion Protein Drug Market Research Report 2025

Global Recombinant Antibody Market Research Report 2025

Protein Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bioequivalent Peptide Drugs Market Research Report 2024

Global Recombinant Protein Biological Research Reagents Market Research Report 2024

Recombinant Protein Therapeutics Market

Global Bio engineered Stent Market Research Report 2024

Global Fc Fusion Protein Drug Market Research Report 2025

Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Insights Forecast to 2030

Recombinant Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Protein Drugs Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions